Besch-Williford C - Search Results

1

Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells.

Liang Y, Besch-Williford C, Benakanakere I, Hyder SM. Liang Y, et al. Int J Oncol. 2007 Oct;31(4):777-84. Int J Oncol. 2007. PMID: 17786308

2

Differential expression of FGF family members in a progestin-dependent BT-474 human breast cancer xenograft model.

López Pérez FR, Liang Y, Besch-Williford CL, Mafuvadze B, Hyder SM. López Pérez FR, et al. Histol Histopathol. 2012 Mar;27(3):337-45. doi: 10.14670/HH-27.337. Histol Histopathol. 2012. PMID: 22237711

3

Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.

Liang Y, Besch-Williford C, Brekken RA, Hyder SM. Liang Y, et al. Cancer Res. 2007 Oct 15;67(20):9929-36. doi: 10.1158/0008-5472.CAN-07-1103. Cancer Res. 2007. PMID: 17942925

4

Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study.

Benakanakere I, Besch-Williford C, Ellersieck MR, Hyder SM. Benakanakere I, et al. Endocr Relat Cancer. 2009 Mar;16(1):85-98. doi: 10.1677/ERC-08-0069. Epub 2008 Dec 15. Endocr Relat Cancer. 2009. PMID: 19075036

5

PRIMA-1 inhibits growth of breast cancer cells by re-activating mutant p53 protein.

Liang Y, Besch-Williford C, Hyder SM. Liang Y, et al. Int J Oncol. 2009 Nov;35(5):1015-23. doi: 10.3892/ijo_00000416. Int J Oncol. 2009. PMID: 19787255

6

Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors.

Liang Y, Besch-Williford C, Benakanakere I, Thorpe PE, Hyder SM. Liang Y, et al. Breast Cancer Res Treat. 2011 Jan;125(2):407-20. doi: 10.1007/s10549-010-0851-x. Epub 2010 Mar 27. Breast Cancer Res Treat. 2011. PMID: 20349129 Free PMC article.

7

Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice.

Liang Y, Benakanakere I, Besch-Williford C, Hyder RS, Ellersieck MR, Hyder SM. Liang Y, et al. Menopause. 2010 Sep-Oct;17(5):1040-7. doi: 10.1097/gme.0b013e3181d3dd0c. Menopause. 2010. PMID: 20461021 Free PMC article.

8

Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors.

Mafuvadze B, Liang Y, Besch-Williford C, Zhang X, Hyder SM. Mafuvadze B, et al. Horm Cancer. 2012 Aug;3(4):160-71. doi: 10.1007/s12672-012-0114-x. Epub 2012 May 9. Horm Cancer. 2012. PMID: 22569706 Free PMC article.

9

The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development.

Carroll CE, Liang Y, Benakanakere I, Besch-Williford C, Hyder SM. Carroll CE, et al. Int J Oncol. 2013 Jan;42(1):179-87. doi: 10.3892/ijo.2012.1675. Epub 2012 Oct 24. Int J Oncol. 2013. PMID: 23123638 Free PMC article.

10

Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071.

Liang Y, Besch-Williford C, Aebi JD, Mafuvadze B, Cook MT, Zou X, Hyder SM. Liang Y, et al. Breast Cancer Res Treat. 2014 Jul;146(1):51-62. doi: 10.1007/s10549-014-2996-5. Epub 2014 May 31. Breast Cancer Res Treat. 2014. PMID: 24878988 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters